Related Experiment Video
Updated: Jun 29, 2026
09:11
A Mouse Model of in Utero Transplantation
Published on: January 27, 2011
Fetal microchimerism and cancer
1Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-100, Seattle, WA 98109, USA. vkgadi@u.washington.edu
Cancer Letters
|October 11, 2008
Summary
Fetal microchimerism, cells from fetus to mother, may protect parous women against breast cancer. This immune surveillance by fetal cells offers a novel defense mechanism against malignancy.
Area of Science:
- Reproductive immunology
- Cancer epidemiology
- Transplantation biology
Background:
- Fetal microchimerism, the presence of fetal cells in mothers, is a known pregnancy outcome.
- While linked to autoimmune diseases, its role in maternal health is unclear.
- Maternal immune tolerance to fetal cells is a complex biological phenomenon.
Purpose of the Study:
- To explore the potential role of fetal microchimerism in maternal health.
- To investigate the hypothesis that fetal microchimerism aids in breast cancer surveillance.
- To synthesize evidence from cancer epidemiology and transplantation biology.
Main Methods:
- Review of existing literature in cancer epidemiology.
- Analysis of data from transplantation biology studies.
- Synthesis of convergent evidence regarding fetal cell persistence and function.
Main Results:
- Fetal microchimerism may play a role in immune surveillance.
- Evidence suggests fetal cells could identify and target malignant cells.
- This microchimeric surveillance may reduce breast cancer risk in women who have given birth.
Conclusions:
- Fetal microchimerism presents a potential protective mechanism against breast cancer in parous women.
- This suggests a novel role for fetal cells in maternal health beyond pregnancy.
- Further research is warranted to elucidate the mechanisms of fetal microchimerism in cancer prevention.
